Advertisement

Topics

Mylan HIV/AIDS NDA Gains Tentative Okay Under President's Program

06:15 EDT 8 Aug 2017 | PharmPro

Mylan receives tentative approval for 'TLD' under PEPFAR (U.S. President's Emergency Plan for AIDS Relief ). Mylan's treatment combines molecules from three originator medicines — ViiV Healthcare's Tivicay, and Epivir and Gilead Science's Viread.
Contributed Author: 
Mylan N.V.
Topics: 

Original Article: Mylan HIV/AIDS NDA Gains Tentative Okay Under President's Program

NEXT ARTICLE

More From BioPortfolio on "Mylan HIV/AIDS NDA Gains Tentative Okay Under President's Program"

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Reverse Transcriptase
Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. It is mainly associated with retroviruses. RT inhibitors are widely used as antiretroviral drugs. RT activitie...